Khalid J. Hirmiz

Windsor, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Complete Remission After Palliative Radiation and Chemotherapy in Stage IV BRCA1-Positive Pancreatic Cancer: A Case of a Patient Who Was Cured 11 Years After Treatment.

Complete Remission After Palliative Radiation and Chemotherapy in Stage IV BRCA1-Positive Pancreatic Cancer: A Case of a Patient Who Was Cured 11 Years After Treatment.

Journal: Cureus

Published: November 27, 2025

Quality of Life of Stereotactic Versus Hypofractionated Radiation Therapy for Inoperable Stage I Non-Small Cell Lung Cancer: Results From the LUSTRE Trial.

Quality of Life of Stereotactic Versus Hypofractionated Radiation Therapy for Inoperable Stage I Non-Small Cell Lung Cancer: Results From the LUSTRE Trial.

Journal: International journal of radiation oncology, biology, physics

Published: August 11, 2025

Long-Term Survival in Human Epidermal Growth Factor Receptor 2-Positive Bone-Only Metastatic Breast Cancer: Trastuzumab, Denosumab, and Potential Synergistic Effects.

Long-Term Survival in Human Epidermal Growth Factor Receptor 2-Positive Bone-Only Metastatic Breast Cancer: Trastuzumab, Denosumab, and Potential Synergistic Effects.

Journal: Cureus

Published: August 27, 2024

Toxicity in patients receiving radiotherapy for ultracentral stage I non-small cell lung cancer: A secondary analysis of the LUSTRE randomized trial.

Toxicity in patients receiving radiotherapy for ultracentral stage I non-small cell lung cancer: A secondary analysis of the LUSTRE randomized trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: April 25, 2024

Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: The LUSTRE Phase 3 Randomized Clinical Trial.

Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: The LUSTRE Phase 3 Randomized Clinical Trial.

Journal: JAMA oncology

Published: November 23, 2023

Adjuvant Chemotherapy and Radiotherapy in Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Clinical Practice Guideline.

Adjuvant Chemotherapy and Radiotherapy in Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Clinical Practice Guideline.

Journal: Current oncology (Toronto, Ont.)

Published: April 19, 2023

Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trial.

Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trial.

Journal: Clinical and translational radiation oncology

Published: August 02, 2022

Early-Stage Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy Outcomes in a Single Institution.

Early-Stage Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy Outcomes in a Single Institution.

Journal: Cureus

Published: February 03, 2022

Survival of patients with pancreatic cancer treated with varied modalities: A single-centre study.

Survival of patients with pancreatic cancer treated with varied modalities: A single-centre study.

Journal: Molecular and clinical oncology

Published: September 21, 2016

Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non-Small-Cell Lung Cancer - Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE Trial.

Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non-Small-Cell Lung Cancer - Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE Trial.

Journal: Clinical lung cancer

Published: August 16, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026